These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


420 related items for PubMed ID: 12698078

  • 1. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J.
    Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078
    [Abstract] [Full Text] [Related]

  • 2. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 15; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 3. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T, Kiyochi H, Honda K, Kobayashi N.
    Transpl Immunol; 2004 Nov 15; 13(3):161-8. PubMed ID: 15381198
    [Abstract] [Full Text] [Related]

  • 4. Regulatory cell-mediated tolerance does not protect against chronic rejection.
    Koshiba T, Kitade H, Van Damme B, Giulietti A, Overbergh L, Mathieu C, Waer M, Pirenne J.
    Transplantation; 2003 Aug 15; 76(3):588-96. PubMed ID: 12923449
    [Abstract] [Full Text] [Related]

  • 5. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.
    Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A, Goto M, Zhang J, Bennet W, Groth CG, Korsgren O, Wennberg L.
    Transplantation; 2003 Apr 27; 75(8):1409-14. PubMed ID: 12717240
    [Abstract] [Full Text] [Related]

  • 7. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1911-8. PubMed ID: 17161344
    [Abstract] [Full Text] [Related]

  • 8. The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance.
    Koshiba T, Van Damme B, Ji P, Sefrioui H, Rutgeerts O, Waer M, Pirenne J.
    Transpl Int; 2003 Jun 20; 16(6):383-90. PubMed ID: 12819868
    [Abstract] [Full Text] [Related]

  • 9. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments.
    Suzuki T, Jin MB, Shimamura T, Yamashita K, Taniguchi M, Nomura M, Yokota R, Fukai M, Magata S, Horiuchi H, Fujita M, Nagashima K, Furukawa H, Todo S.
    Transpl Int; 2004 Nov 20; 17(10):574-84. PubMed ID: 15592714
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M, Mokhtari GK, Balsam LB, Cooke DT, Kofidis T, Zwierzchonievska M, Robbins RC.
    J Heart Lung Transplant; 2005 Apr 20; 24(4):446-53. PubMed ID: 15797747
    [Abstract] [Full Text] [Related]

  • 11. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J, Xia J, Zhang K, Xu L.
    J Surg Res; 2009 Nov 20; 157(1):81-90. PubMed ID: 19577762
    [Abstract] [Full Text] [Related]

  • 12. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS, Nogueira-Martins MF, Silva HT, Pestana JO, Bueno V.
    Transplant Proc; 2004 May 20; 36(4):1015-7. PubMed ID: 15194353
    [Abstract] [Full Text] [Related]

  • 13. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T, Yamane M, Sano Y, Aoe M, Date H, Shimizu N.
    Transpl Immunol; 2007 Jun 20; 17(4):249-54. PubMed ID: 17493527
    [Abstract] [Full Text] [Related]

  • 14. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K.
    J Immunol; 1998 Jun 01; 160(11):5493-9. PubMed ID: 9605152
    [Abstract] [Full Text] [Related]

  • 15. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
    Sugito K, Inoue M, Ikeda T, Hagiwara N, Koshinaga T, Kusafuka T.
    Transplant Proc; 2007 Dec 01; 39(10):3432-5. PubMed ID: 18089399
    [Abstract] [Full Text] [Related]

  • 16. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y.
    J Immunol; 1998 May 15; 160(10):5037-44. PubMed ID: 9590253
    [Abstract] [Full Text] [Related]

  • 17. Effect of FTY720 in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1.
    Sugito K, Koshinaga T, Inoue M, Ikeda T, Hagiwara N, Fukuzawa M.
    Transplant Proc; 2005 Dec 15; 37(10):4472-4. PubMed ID: 16387148
    [Abstract] [Full Text] [Related]

  • 18. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH, Yan Y, De Boer B, Bishop GA, House AK.
    Transplantation; 2003 Feb 15; 75(3):368-74. PubMed ID: 12589161
    [Abstract] [Full Text] [Related]

  • 19. Regulation of donor T cells in the tolerant rats to graft-versus-host disease by FTY720 following small bowel transplantation.
    Song J, Ito T, Matsuda C, Tanemura M, Nishida T, Nozawa M, Sawa Y.
    Transplant Proc; 2006 Dec 15; 38(10):3181-3. PubMed ID: 17175216
    [Abstract] [Full Text] [Related]

  • 20. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
    Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y.
    Transplantation; 2004 Jun 27; 77(12):1826-33. PubMed ID: 15223899
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.